Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

MMP inhibitor from British Biotech effective against oxidant-induced lung injury

May 14, 1997

Immunex reports new chemokine-binding protein

May 14, 1997

Dura acquires two intranasal steroid products from Syntex

May 13, 1997

Sequana and Boehringer Ingelheim expand alliance for asthma research

May 12, 1997

Bradykinin antagonists from Fujisawa

May 9, 1997

Kowa/Vrije University researchers identify potent CysLT1 receptor antagonists

May 7, 1997

FDA grants SciClone orphan drug status for CPX

May 6, 1997

Sanofi claims HLE inhibitors

May 6, 1997

Nacystelyn promising alternative to NAC for lung antioxidant therapy

May 5, 1997

Dual D2/beta2 agonists disclosed by Astra

May 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...